Compared to oligodendrogliomas and GBM, astrocytomas showed a significantly lower proportion of ATRX+ tumor cells, which is also consistent with the phenotype of ATRX mutations in astrocytomas [24]. This evidence concerns the gene ATRX and astrocytoma (excluding glioblastoma).